These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18528295)

  • 1. Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade.
    Breunis WB; Tarazona-Santos E; Chen R; Kiley M; Rosenberg SA; Chanock SJ
    J Immunother; 2008; 31(6):586-90. PubMed ID: 18528295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.
    Misra MK; Pandey SK; Kapoor R; Sharma RK; Agrawal S
    Pharmacogenet Genomics; 2015 Jan; 25(1):19-29. PubMed ID: 25356901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.
    Joshita S; Umemura T; Yoshizawa K; Katsuyama Y; Tanaka E; Nakamura M; Ishibashi H; Ota M;
    J Hepatol; 2010 Sep; 53(3):537-41. PubMed ID: 20557968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues.
    Phan GQ; Weber JS; Sondak VK
    Ann Surg Oncol; 2008 Nov; 15(11):3014-21. PubMed ID: 18716842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
    Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of functional genetic variants of CTLA4 with reduced serum CTLA4 protein levels and increased risk of idiopathic recurrent miscarriages.
    Misra MK; Mishra A; Phadke SR; Agrawal S
    Fertil Steril; 2016 Oct; 106(5):1115-1123.e6. PubMed ID: 27351445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
    Yuan J; Gnjatic S; Li H; Powel S; Gallardo HF; Ritter E; Ku GY; Jungbluth AA; Segal NH; Rasalan TS; Manukian G; Xu Y; Roman RA; Terzulli SL; Heywood M; Pogoriler E; Ritter G; Old LJ; Allison JP; Wolchok JD
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20410-5. PubMed ID: 19074257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.
    Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P
    Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
    Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).
    Weber J
    Oncologist; 2008; 13 Suppl 4():16-25. PubMed ID: 19001147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.
    Sun L; Meng Y; Xie Y; Zhang H; Zhang Z; Wang X; Jiang B; Li W; Li Y; Yang Z
    PLoS One; 2014; 9(7):e101986. PubMed ID: 25003519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.
    de Joode K; Mora AR; van Schaik RHN; Zippelius A; van der Veldt A; Gerard CL; Läubli H; Michielin O; von Moos R; Joerger M; Levesque MP; Aeppli S; Mangana J; Mangas C; Trost N; Meyer S; Parvex SL; Mathijssen R; Metaxas Y
    J Immunother; 2024 Jun; 47(5):190-194. PubMed ID: 38318726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients.
    Guo Y; Fan Y; Qiu J; Liu Y; Gao J; Guo F
    PLoS One; 2012; 7(12):e51723. PubMed ID: 23300559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
    Di Giacomo AM; Danielli R; Guidoboni M; Calabrò L; Carlucci D; Miracco C; Volterrani L; Mazzei MA; Biagioli M; Altomonte M; Maio M
    Cancer Immunol Immunother; 2009 Aug; 58(8):1297-306. PubMed ID: 19139884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.
    Guo YF; Qiu JX; Guo F; Liu Y; Shang MH
    Biomed Res Int; 2015; 2015():986780. PubMed ID: 25667935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
    Beck KE; Blansfield JA; Tran KQ; Feldman AL; Hughes MS; Royal RE; Kammula US; Topalian SL; Sherry RM; Kleiner D; Quezado M; Lowy I; Yellin M; Rosenberg SA; Yang JC
    J Clin Oncol; 2006 May; 24(15):2283-9. PubMed ID: 16710025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.
    Li F; Yuan W; Wu X
    Ann Hum Genet; 2018 Nov; 82(6):358-369. PubMed ID: 30009380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.